Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

PURPOSE: The purpose of this study is to define which visual acuity (VA) measurements are the best indicators of high-quality care for patients receiving intravitreal ranibizumab for neovascular age-related macular degeneration (nAMD). METHODS: Analysis of prospectively collected data recorded with...

Full description

Bibliographic Details
Main Authors: Ross, A, Donachie, P, Sallam, A, Stratton, I, Mohamed, Q, Scanlon, P, Kirkpatrick, J, Johnston, R
Format: Journal article
Language:English
Published: 2013

Similar Items

Similar Items